CTOs on the Move

Innova Medical Group

www.innovamedgroup.com

 
Innova Medical Group is a global health screening and diagnostic innovator driven to dramatically improve health outcomes worldwide with equitable, high-value testing solutions. Our strategic and iterative approach enables us to create, build and deploy a myriad of accessible tests customized to meet and empower the user at their point of need. With a panoramic vision spanning the present to the future, we develop trusted solutions that are both intuitive and secure to use. We quickly and nimbly became the world`s largest provider of COVID-19 tests, and we are determined to execute on this model across infectious disease, other chronic ...
  • Number of Employees: 100-250
  • Annual Revenue: $1-10 Million

Executives

Name Title Contact Details

Similar Companies

Pacific Bridge Medical

Pacific Bridge Medical is a Bethesda, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Whisper

Whisper is a team of artificial intelligence, hearing care, hardware, and software experts coming together to solve the challenge of providing better hearing. We set out to make the Whisper Hearing System so our parents, grandparents, friends, and teammates can have a tomorrow that sounds even better than today.

Lexion Medical LLC

Lexion Medical LLC is one of the leading companies in the Healthcare, Pharmaceuticals, and Biotech sector.

Stago

Stago is a Parsippany, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

HeartBeam

HeartBeam, Inc. (NASDAQ: BEAT) is a development stage digital healthcare company with proprietary ECG telemedicine technology that will redefine the way high risk cardiovascular patients are diagnosed in an ambulatory setting at any time and any place. Its breakthrough solution employs a reusable, credit card sized, 3D vector ECG recording device and cloud-based software capable of assisting a physician in diagnosing a wide range of cardiovascular disease. HeartBeam is initially focusing on a huge unmet need of helping diagnose heart attacks in patients outside of a medical institution. No single lead ECG technology can offer this value to patients and their physicians. This underserved market is several times larger than the cardiac arrhythmia detection market based on the prevalence of patients with coronary artery disease at high risk of heart attack